Banggulan, Roy .

HRN: 16-79-08  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/07/2024
06/08/2024
IVT
500 MG
1 Hr PTOR
Urolithiasis
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: